ArticleOncotarget2016

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

Małgorzata Czyż et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.